Literature DB >> 16364671

Laminopathies: multisystem dystrophy syndromes.

Katherine N Jacob1, Abhimanyu Garg.   

Abstract

Laminopathies are a heterogeneous group of genetic disorders due to abnormalities in type A lamins and can manifest varied clinical features affecting many organs including the skeletal and cardiac muscle, adipose tissue, nervous system, cutaneous tissue, and bone. Mutations in the gene encoding lamins A and C (LMNA) cause primary laminopathies, including various types of lipodystrophies, muscular dystrophies and progeroid syndromes, mandibuloacral dysplasia, dilated cardiomyopathies, and restrictive dermopathy. The secondary laminopathies are due to mutations in ZMPSTE24 gene which encodes for a zinc metalloproteinase involved in processing of prelamin A into mature lamin A and cause mandibuloacral dysplasia and restrictive dermopathy. Skin fibroblast cells from many patients with laminopathies show a range of abnormal nuclear morphology including bleb formation, honeycombing, and presence of multi-lobulated nuclei. The mechanisms by which mutations in LMNA gene cause multisystem dystrophy are an active area of current investigation. Further studies are needed to understand the underlying mechanisms of marked pleiotropy in laminopathies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16364671     DOI: 10.1016/j.ymgme.2005.10.018

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  39 in total

1.  Evaluation of micronucleus and erythrocytic nuclear abnormalities in Balkan whip snake Hierophis gemonensis.

Authors:  Ivancica Strunjak-Perovic; Duje Lisicic; Rozelindra Coz-Rakovac; Natalija Topic Popovic; Margita Jadan; Vesna Benkovic; Zoran Tadic
Journal:  Ecotoxicology       Date:  2010-08-11       Impact factor: 2.823

2.  Collagen expression in fibroblasts with a novel LMNA mutation.

Authors:  Desiree Nguyen; Dru F Leistritz; Lesley Turner; David MacGregor; Kamal Ohson; Paul Dancey; George M Martin; Junko Oshima
Journal:  Biochem Biophys Res Commun       Date:  2006-11-27       Impact factor: 3.575

Review 3.  Laminopathies: multiple disorders arising from defects in nuclear architecture.

Authors:  Veena K Parnaik; Kaliyaperumal Manju
Journal:  J Biosci       Date:  2006-09       Impact factor: 1.826

4.  Mislocalization of prelamin A Tyr646Phe mutant to the nuclear pore complex in human embryonic kidney 293 cells.

Authors:  Yong Pan; Abhimanyu Garg; Anil K Agarwal
Journal:  Biochem Biophys Res Commun       Date:  2007-01-31       Impact factor: 3.575

5.  HIV protease inhibitors and nuclear lamin processing: getting the right bells and whistles.

Authors:  Steven Gerard Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-20       Impact factor: 11.205

6.  Seasonality of nuclear abnormalities in gilthead sea bream Sparus aurata (L.) erythrocytes.

Authors:  Ivancica Strunjak-Perovic; Rozelindra Coz-Rakovac; Natalija Topic Popovic; Margita Jadan
Journal:  Fish Physiol Biochem       Date:  2008-03-11       Impact factor: 2.794

Review 7.  "IF-pathies": a broad spectrum of intermediate filament-associated diseases.

Authors:  M Bishr Omary
Journal:  J Clin Invest       Date:  2009-07-01       Impact factor: 14.808

8.  Accelerated telomere shortening and replicative senescence in human fibroblasts overexpressing mutant and wild-type lamin A.

Authors:  Shurong Huang; Rosa Ana Risques; George M Martin; Peter S Rabinovitch; Junko Oshima
Journal:  Exp Cell Res       Date:  2007-08-16       Impact factor: 3.905

9.  Barrier-to-autointegration factor proteome reveals chromatin-regulatory partners.

Authors:  Rocío Montes de Oca; Christopher J Shoemaker; Marjan Gucek; Robert N Cole; Katherine L Wilson
Journal:  PLoS One       Date:  2009-09-16       Impact factor: 3.240

Review 10.  Molecular genetic analysis of podocyte genes in focal segmental glomerulosclerosis--a review.

Authors:  M M Löwik; P J Groenen; E N Levtchenko; L A Monnens; L P van den Heuvel
Journal:  Eur J Pediatr       Date:  2009-06-27       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.